ARRAY Technologies, Inc. Reports Financial Results for the Third Quarter 2024 – Delivers exceptional gross margin growth and continued operational momentum
ARRAY Technologies (ARRY) reported Q3 2024 financial results with revenue of $231.4 million and gross margin of 33.8%. The company posted a net loss of $155.4 million, including a $162 million non-cash goodwill impairment charge. Adjusted EBITDA reached $46.7 million, with adjusted gross margin at 35.4%. The company maintains a healthy orderbook of $2 billion, with over 20% representing OmniTrack™ orders. For full-year 2024, ARRAY expects revenue between $900-920 million, adjusted EBITDA of $170-180 million, and free cash flow of $100-115 million. The company anticipates adjusted gross margin of approximately 34% for the year.
ARRAY Technologies (ARRY) ha riportato i risultati finanziari del terzo trimestre 2024 con un fatturato di 231,4 milioni di dollari e un margine lordo del 33,8%. L'azienda ha registrato una perdita netta di 155,4 milioni di dollari, inclusa una svalutazione dell'avviamento non monetaria di 162 milioni di dollari. L'EBITDA corretto ha raggiunto i 46,7 milioni di dollari, con un margine lordo corretto al 35,4%. L'azienda mantiene un portafoglio ordini sano di 2 miliardi di dollari, di cui oltre il 20% rappresenta ordini OmniTrack™. Per l'intero anno 2024, ARRAY prevede un fatturato compreso tra 900 e 920 milioni di dollari, un EBITDA corretto di 170-180 milioni di dollari e un flusso di cassa libero di 100-115 milioni di dollari. L'azienda prevede un margine lordo corretto di circa il 34% per l'anno.
ARRAY Technologies (ARRY) informó los resultados financieros del tercer trimestre de 2024 con ingresos de 231.4 millones de dólares y un margen bruto del 33.8%. La compañía registró una pérdida neta de 155.4 millones de dólares, incluyendo un cargo por deterioro del fondo de comercio no monetario de 162 millones de dólares. El EBITDA ajustado alcanzó los 46.7 millones de dólares, con un margen bruto ajustado del 35.4%. La empresa mantiene un libro de pedidos saludable de 2 mil millones de dólares, con más del 20% representando órdenes de OmniTrack™. Para el año completo de 2024, ARRAY espera ingresos entre 900 y 920 millones de dólares, un EBITDA ajustado de 170 a 180 millones de dólares y un flujo de caja libre de 100 a 115 millones de dólares. La empresa anticipa un margen bruto ajustado de aproximadamente el 34% para el año.
ARRAY Technologies (ARRY)는 2024년 3분기 재무 결과를 보고하면서 매출 2억 3,140만 달러와 총 모가지를 33.8%로 발표했습니다. 이 회사는 1억 5,540만 달러의 순손실을 기록했으며, 여기에는 1억 6,200만 달러의 비현금 goodwill 손상 차손이 포함됩니다. 조정 EBITDA는 4,670만 달러에 달하며, 조정된 총 마진은 35.4%입니다. 회사는 20% 이상이 OmniTrack™주문을 차지하는 20억 달러의 건전한 주문서를 유지하고 있습니다. 2024년도 전체로 ARRAY는 9억에서 9억 2천만 달러 간의 매출, 1억 7천만에서 1억 8천만 달러 간의 조정 EBITDA, 1억에서 1억 1,500만 달러의 자유 현금 흐름을 예상하고 있습니다. 이 회사는 연간 약 34%의 조정 총 마진을 예상합니다.
ARRAY Technologies (ARRY) a rapporté ses résultats financiers du troisième trimestre 2024 avec un chiffre d'affaires de 231,4 millions de dollars et une marge brute de 33,8%. La société a enregistré une perte nette de 155,4 millions de dollars, comprenant une charge de dépréciation du goodwill non monétaire de 162 millions de dollars. L'EBITDA ajusté a atteint 46,7 millions de dollars, avec une marge brute ajustée à 35,4%. L'entreprise maintient un carnet de commandes sain de 2 milliards de dollars, dont plus de 20% représentent des commandes OmniTrack™. Pour l'année entière 2024, ARRAY prévoit un chiffre d'affaires compris entre 900 et 920 millions de dollars, un EBITDA ajusté de 170 à 180 millions de dollars, et un flux de trésorerie disponible de 100 à 115 millions de dollars. L'entreprise anticipe une marge brute ajustée d'environ 34% pour l'année.
ARRAY Technologies (ARRY) berichtete über die finanziellen Ergebnisse des dritten Quartals 2024 mit einem Umsatz von 231,4 Millionen Dollar und einer Bruttomarge von 33,8%. Das Unternehmen verzeichnete einen Nettoverlust von 155,4 Millionen Dollar, einschließlich einer nicht zahlungswirksamen Goodwill-Abwertung in Höhe von 162 Millionen Dollar. Das bereinigte EBITDA erreichte 46,7 Millionen Dollar, bei einer bereinigten Bruttomarge von 35,4%. Das Unternehmen hat ein gesundes Auftragsvolumen von 2 Milliarden Dollar, wobei über 20% die Aufträge von OmniTrack™ ausmachen. Für das Gesamtjahr 2024 erwartet ARRAY einen Umsatz zwischen 900 und 920 Millionen Dollar, ein bereinigtes EBITDA von 170 bis 180 Millionen Dollar sowie einen freien Cashflow von 100 bis 115 Millionen Dollar. Das Unternehmen rechnet mit einer bereinigten Bruttomarge von etwa 34% für das Jahr.
- Strong adjusted gross margin of 35.4% in Q3 2024
- Robust orderbook at $2 billion
- Projected free cash flow of $100-115 million for 2024
- Expected adjusted gross margin of 34% for full-year 2024
- Net loss of $155.4 million in Q3 2024
- $162 million non-cash goodwill impairment charge
- Anticipated decline in U.S. and international volumes with lower ASP compared to 2023
- Continued softness in Brazil market
Insights
ARRAY Technologies delivered mixed Q3 2024 results with significant margin improvements despite revenue challenges. Revenue of
The
Key concerns include persistent U.S. market challenges such as interconnection delays and equipment shortages, though IRA incentives and improving financing conditions could provide tailwinds for 2025.
The solar tracking market dynamics reveal interesting shifts in ARRAY's positioning. The growing adoption of OmniTrack™ indicates successful market penetration in challenging terrain installations, expanding the company's addressable market. The focus on domestic content capability aligns well with current market preferences and regulatory incentives.
Despite near-term challenges, the company's strategic positioning for IRA benefits and domestic production advantages suggests potential market share gains. The maintained
Third Quarter 2024 Highlights
- Revenue of
$231.4 million - Gross Margin of
33.8% - Adjusted gross margin of
35.4% (1) - Net loss to common shareholders of
$(155.4) million - Net loss to common shareholders inclusive of
$162 million non-cash goodwill impairment charge associated with the 2022 STI acquisition
- Net loss to common shareholders inclusive of
- Adjusted EBITDA(1) of
$46.7 million - Basic and diluted net loss per share of
$(1.02) - Adjusted diluted net income per share(1) of
$0.17
ALBUQUERQUE, N.M., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a global leader in utility-scale solar tracking, today announced financial results for its third quarter ended September 30, 2024.
“ARRAY had another impressive quarter of operational execution, achieving revenue within our guidance range and strong profitability, as evidenced by our adjusted gross margin of
Mr. Hostetler continued, “As we look to 2025 and beyond, we will continue to work with our customers to understand their challenges and expected timing of projects. While there are likely some persistent headwinds that will continue to impact the U.S. market, such as interconnection and permitting delays, shortages of long lead-time electrical equipment, and labor constraints, we also believe there are dynamics that will facilitate incremental improvement in 2025. These factors include the financing environment, clarity around AD/CVD tariffs for imported modules, and additional transparency on IRA incentives for utility-scale solar. As we assess these dynamics, we feel optimistic about strong double-digit top-line growth in 2025, but we will continue to do our due diligence within this environment. As always, ARRAY will remain steadfast and focused on the key elements within our control – excellent customer engagement and support, operational execution, and product enhancements and innovation.”
Executed Contracts and Awarded Orders
Total executed contracts and awarded orders at September 30, 2024 were
Full Year 2024 Guidance
For the year ending December 31, 2024, the Company expects:
- Revenue to be in the range of
$900 million to$920 million - Adjusted EBITDA(2) to be in the range of
$170 million to$180 million - Adjusted net income per share(2) to be in the range of
$0.60 t o$0.65
The narrowing of our top-line guidance is reflective of continued softness in the Brazil market, which was anticipated within the range of scenarios in our guide. We expect U.S. and international volumes to be down with declining ASP when compared to 2023. We now anticipate adjusted gross margin of approximately
Conference Call Information
ARRAY management will host a conference call today at 5:00 p.m. Eastern Time to discuss the Company’s financial results. The conference call can be accessed live over the phone by dialing (877)-869-3847 (domestic) or (201)-689-8261 (international). A telephonic replay will be available approximately three hours after the call by dialing (877)-660-6853, or for international callers, (201)-612-7415. The passcode for the live call and the replay is 13748999. The replay will be available until 11:59 p.m. (ET) on November 21, 2024.
Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company's website at http://ir.arraytechinc.com. The online replay will be available for 30 days on the same website immediately following the call.
To learn more about ARRAY Technologies, please visit the Company's website at http://ir.arraytechinc.com.
About ARRAY Technologies, Inc.
ARRAY Technologies (NASDAQ: ARRY) is a leading global renewable energy company and provider of utility-scale solar tracking technology. Engineered to withstand the harshest conditions on the planet, ARRAY’s high-quality solar trackers and sophisticated software maximize energy production, accelerating the adoption of cost-effective and sustainable energy. Founded and headquartered in the United States, ARRAY relies on its diversified global supply chain and customer-centric approach to deliver, commission, and support solar energy developments around the world, lighting the way to a brighter, smarter future for clean energy. For more news and information on ARRAY, please visit arraytechinc.com.
Investor Relations Contact:
ARRAY Technologies, Inc.
Investor Relations
505-437-0010
investors@arraytechinc.com
Forward-Looking Statements
This press release contains forward-looking statements that are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include information concerning our projected future results of operations, project timing, sales volume, and industry and regulatory environment. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” "seek," “should,” “will,” “would” or similar expressions and the negatives of those terms.
ARRAY’s actual results and the timing of events could materially differ from those anticipated in such forward-looking statements as a result of certain risks, uncertainties and other factors, including without limitation: changes in growth or rate of growth in demand for solar energy projects; competitive pressures within our industry; a loss of one or more of our significant customers, their inability to perform under their contracts, or their default in payment; a drop in the price of electricity derived from the utility grid or from alternative energy sources; a failure to maintain effective internal controls over financial reporting; a further increase in interest rates, or a reduction in the availability of tax equity or project debt capital in the global financial markets, which could make it difficult for customers to finance the cost of a solar energy system; electric utility industry policies and regulations, and any subsequent changes, may present technical, regulatory and economic barriers to the purchase and use of solar energy systems, which may significantly reduce demand for our products or harm our ability to compete; the interruption of the flow of materials from international vendors, which could disrupt our supply chain, including as a result of the imposition of additional duties, tariffs and other charges or restrictions on imports and exports; geopolitical, macroeconomic and other market conditions unrelated to our operating performance including the military conflict in Ukraine and Russia, the Israel-Hamas war, attacks on shipping in the Red Sea and rising inflation and interest rates; changes in the global trade environment, including the imposition of import tariffs or other import restrictions; our ability to convert our orders in backlog into revenue; fluctuations in our results of operations across fiscal periods, which could make our future performance difficult to predict and could cause our results of operations for a particular period to fall below expectations; the reduction, elimination or expiration, or our failure to optimize the benefits of government incentives for, or regulations mandating the use of, renewable energy and solar energy, particularly in relation to our competitors; failure to, or incurrence of significant costs in order to, obtain, maintain, protect, defend or enforce, our intellectual property and other proprietary right; significant changes in the cost of raw materials; defects or performance problems in our products, which could result in loss of customers, reputational damage and decreased revenue; delays, disruptions or quality control problems in our product development operations; our ability to obtain key personnel or failure to attract additional qualified personnel; additional business, financial, regulatory and competitive risks due to our continued planned expansion into new markets; cybersecurity or other data incidents, including unauthorized disclosure of personal or sensitive data or theft of confidential information; failure to implement and maintain effective internal controls over financial reporting; risks related to actual or threatened public health epidemics, pandemics, outbreaks or crises, such as the COVID-19 pandemic, which could have a material and adverse effect on our business, results of operations and financial condition; changes to tax laws and regulations that are applied adversely to us or our customers, which could materially adversely affect our business, financial condition, results of operations and prospects, including our ability to optimize those changes brought about by the passage of the Inflation Reduction Act; and the other risks and uncertainties described in more detail in the Company’s most recent Annual Report on Form 10-K and other documents on file with the SEC, each of which can be found on our website, www.arraytechinc.com.
Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Non-GAAP Financial Information
This press release includes certain financial measures that are not presented in accordance with U.S. generally accepted accounting principles (“GAAP”), including Adjusted gross profit, Adjusted gross margin, Adjusted EBITDA, Adjusted net income, Adjusted net income per share, and Free cash flow. We define Adjusted gross profit as gross profit plus (i) developed technology amortization and (ii) other costs if applicable. We define Adjusted EBITDA as net income (loss) plus (i) other (income) expense, (ii) foreign currency transaction (gain) loss, (iii) preferred dividends and accretion, (iv) interest expense, (v) income tax (benefit) expense, (vi) depreciation expense, (vii) amortization of intangibles, (viii) amortization of developed technology, (ix) equity-based compensation, (x) change in fair value of contingent consideration, (xi) goodwill impairment, (xii) certain legal expenses, (xiii) certain acquisition related costs if applicable, and (xiv) other costs. We define Adjusted net income as net income to common shareholders plus (i) amortization of intangibles, (ii) amortization of developed technology, (iii) amortization of debt discount and issuance costs (iv) preferred accretion, (v) equity-based compensation, (vi) change in fair value of derivative assets, (vii) change in fair value of contingent consideration, (viii) goodwill impairment, (ix) certain legal expenses, (x) certain acquisition related costs if applicable, (xi) other costs, and (xii) income tax (benefit) expense of adjustments. We define Free cash flow as Cash provided by (used in) operating activities less purchase of property, plant and equipment. A detailed reconciliation between GAAP results and results excluding special items (“non-GAAP”) is included within this presentation. We calculate net income (loss) per share as net income (loss) to common shareholders divided by the basic and diluted weighted average number of shares outstanding for the applicable period and we define Adjusted net income per share as Adjusted net income (as detailed above) divided by the basic and diluted weighted average number of shares outstanding for the applicable period.
We believe that these non-GAAP financial measures are provided to enhance the reader’s understanding of our past financial performance and our prospects for the future. Our management team uses these non-GAAP financial measures in assessing the Company’s performance, as well as in planning and forecasting future periods. The non-GAAP financial information is presented for supplemental informational purposes only and should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled non-GAAP measures used by other companies.
Among other limitations, Adjusted gross profit, Adjusted gross margin, Adjusted EBITDA and Adjusted net income do not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments; do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations; do not reflect income tax expense or benefit; and other companies in our industry may calculate Adjusted gross profit, Adjusted gross margin, Adjusted EBITDA and Adjusted net income differently than we do, which limits their usefulness as comparative measures. Because of these limitations, Adjusted gross profit, Adjusted gross margin, Adjusted EBITDA and adjusted net income should not be considered in isolation or as substitutes for performance measures calculated in accordance with GAAP. We compensate for these limitations by relying primarily on our GAAP results and using Adjusted gross profit, Adjusted EBITDA and Adjusted net income on a supplemental basis. You should review the reconciliation of gross profit to Adjusted gross profit and net income (loss) to Adjusted EBITDA and Adjusted net income below and not rely on any single financial measure to evaluate our business.
(1) A reconciliation of the most comparable GAAP measure to its Non-GAAP measure is included below.
(2) A reconciliation of projected Adjusted gross margin, Adjusted EBITDA and Adjusted net income per share, which are forward-looking measures that are not prepared in accordance with GAAP, to the most directly comparable GAAP financial measures, is not provided because we are unable to provide such reconciliation without unreasonable effort. The inability to provide a quantitative reconciliation is due to the uncertainty and inherent difficulty predicting the occurrence, the financial impact and the periods in which the components of the applicable GAAP measures and non-GAAP adjustments may be recognized. The GAAP measures may include the impact of such items as non-cash share-based compensation, revaluation of the fair-value of our contingent consideration, and the tax effect of such items, in addition to other items we have historically excluded from Adjusted EBITDA and Adjusted net income per share. We expect to continue to exclude these items in future disclosures of these non-GAAP measures and may also exclude other similar items that may arise in the future (collectively, “non-GAAP adjustments”). The decisions and events that typically lead to the recognition of non-GAAP adjustments are inherently unpredictable as to if or when they may occur. As such, for our 2024 outlook, we have not included estimates for these items and are unable to address the probable significance of the unavailable information, which could be material to future results.
| ARRAY Technologies, Inc. and Subsidiaries Consolidated Balance Sheets (unaudited) (in thousands, except per share and share amounts) | |||||||
| September 30, 2024 | December 31, 2023 | ||||||
| ASSETS | |||||||
| Current assets | |||||||
| Cash and cash equivalents | $ | 332,372 | $ | 249,080 | |||
| Accounts receivable, net of allowance of | 282,117 | 332,152 | |||||
| Inventories | 195,697 | 161,964 | |||||
| Prepaid expenses and other | 92,096 | 89,085 | |||||
| Total current assets | 902,282 | 832,281 | |||||
| Property, plant and equipment, net | 27,629 | 27,893 | |||||
| Goodwill | 250,873 | 435,591 | |||||
| Other intangible assets, net | 301,599 | 354,389 | |||||
| Deferred income tax assets | 15,716 | 15,870 | |||||
| Other assets | 65,005 | 40,717 | |||||
| Total assets | $ | 1,563,104 | $ | 1,706,741 | |||
| LIABILITIES, REDEEMABLE PERPETUAL PREFERRED STOCK AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities | |||||||
| Accounts payable | $ | 149,202 | $ | 119,498 | |||
| Accrued expenses and other | 48,952 | 70,211 | |||||
| Accrued warranty reserve | 1,503 | 2,790 | |||||
| Income tax payable | 1,437 | 5,754 | |||||
| Deferred revenue | 112,618 | 66,488 | |||||
| Current portion of contingent consideration | 1,873 | 1,427 | |||||
| Current portion of debt | 28,055 | 21,472 | |||||
| Other current liabilities | 31,248 | 48,051 | |||||
| Total current liabilities | 374,888 | 335,691 | |||||
| Deferred income tax liabilities | 55,253 | 66,858 | |||||
| Contingent consideration, net of current portion | 6,792 | 8,936 | |||||
| Other long-term liabilities | 16,885 | 20,428 | |||||
| Long-term warranty | 3,889 | 3,372 | |||||
| Long-term debt, net of current portion | 648,318 | 660,948 | |||||
| Total liabilities | 1,106,025 | 1,096,233 | |||||
| Commitments and contingencies (Note 11) | |||||||
| Series A Redeemable Perpetual Preferred Stock of | 392,592 | 351,260 | |||||
| Stockholders’ equity | |||||||
| Preferred stock of | — | — | |||||
| Common stock of | 151 | 151 | |||||
| Additional paid-in capital | 308,347 | 344,517 | |||||
| Accumulated deficit | (243,721 | ) | (130,230 | ) | |||
| Accumulated other comprehensive income | (290 | ) | 44,810 | ||||
| Total stockholders’ equity | 64,487 | 259,248 | |||||
| Total liabilities, redeemable perpetual preferred stock and stockholders’ equity | $ | 1,563,104 | $ | 1,706,741 | |||
| ARRAY Technologies, Inc. and Subsidiaries Consolidated Statements of Operations (unaudited) (in thousands, except per share amounts) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Revenue | $ | 231,406 | $ | 350,438 | $ | 640,575 | $ | 1,234,936 | |||||||
| Cost of revenue | |||||||||||||||
| Cost of product and service revenue | 149,452 | 259,419 | 410,299 | 892,696 | |||||||||||
| Amortization of developed technology | 3,639 | 3,640 | 10,918 | 10,918 | |||||||||||
| Total cost of revenue | 153,091 | 263,059 | 421,217 | 903,614 | |||||||||||
| Gross profit | 78,315 | 87,379 | 219,358 | 331,322 | |||||||||||
| Operating expenses | |||||||||||||||
| General and administrative | 40,149 | 37,432 | 114,904 | 115,825 | |||||||||||
| Change in fair value of contingent consideration | (39 | ) | 190 | (271 | ) | 2,232 | |||||||||
| Depreciation and amortization | 8,880 | 9,552 | 27,384 | 29,361 | |||||||||||
| Goodwill impairment | 162,000 | — | 162,000 | — | |||||||||||
| Total operating expenses | 210,990 | 47,174 | 304,017 | 147,418 | |||||||||||
| (Loss) income from operations | (132,675 | ) | 40,205 | (84,659 | ) | 183,904 | |||||||||
| Other loss, net | (682 | ) | (446 | ) | (1,662 | ) | (127 | ) | |||||||
| Interest income | 4,223 | 3,425 | 12,685 | 6,124 | |||||||||||
| Foreign currency (loss) gain, net | (106 | ) | 207 | (1,073 | ) | 273 | |||||||||
| Interest expense | (8,264 | ) | (13,064 | ) | (25,818 | ) | (35,372 | ) | |||||||
| Total other expense, net | (4,829 | ) | (9,878 | ) | (15,868 | ) | (29,102 | ) | |||||||
| (Loss) income before income tax expense | (137,504 | ) | 30,327 | (100,527 | ) | 154,802 | |||||||||
| Income tax expense | 3,850 | 7,229 | 12,964 | 36,904 | |||||||||||
| Net (loss) income | (141,354 | ) | 23,098 | (113,491 | ) | 117,898 | |||||||||
| Preferred dividends and accretion | 14,080 | 13,091 | 41,332 | 38,359 | |||||||||||
| Net (loss) income to common shareholders | $ | (155,434 | ) | $ | 10,007 | $ | (154,823 | ) | $ | 79,539 | |||||
| (Loss) income per common share | |||||||||||||||
| Basic | $ | (1.02 | ) | $ | 0.07 | $ | (1.02 | ) | $ | 0.52 | |||||
| Diluted | $ | (1.02 | ) | $ | 0.07 | $ | (1.02 | ) | $ | 0.52 | |||||
| Weighted average number of common shares outstanding | |||||||||||||||
| Basic | 151,923 | 151,068 | 151,691 | 150,865 | |||||||||||
| Diluted | 151,923 | 152,323 | 151,691 | 152,083 | |||||||||||
| ARRAY Technologies, Inc. and Subsidiaries Consolidated Statements of Cash Flows (unaudited) (in thousands) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Operating activities | |||||||||||||||
| Net (loss) income | $ | (141,354 | ) | $ | 23,098 | $ | (113,491 | ) | $ | 117,898 | |||||
| Adjustments to net income: | |||||||||||||||
| Goodwill impairment | 162,000 | — | 162,000 | — | |||||||||||
| Provision for bad debts | 1,719 | 24 | 3,415 | (117 | ) | ||||||||||
| Deferred tax benefit | (3,778 | ) | (532 | ) | (7,279 | ) | (2,328 | ) | |||||||
| Depreciation and amortization | 9,559 | 9,904 | 29,015 | 30,318 | |||||||||||
| Amortization of developed technology | 3,639 | 3,640 | 10,918 | 10,918 | |||||||||||
| Amortization of debt discount and issuance costs | 1,551 | 4,125 | 4,652 | 9,123 | |||||||||||
| Equity-based compensation | 2,015 | 3,384 | 6,851 | 11,695 | |||||||||||
| Change in fair value of contingent consideration | (39 | ) | 189 | (271 | ) | 2,232 | |||||||||
| Warranty provision | 97 | (28 | ) | 36 | 451 | ||||||||||
| Write-down of inventories | 1,254 | 1,129 | 2,481 | 4,587 | |||||||||||
| Changes in operating assets and liabilities, net of business acquisition: | |||||||||||||||
| Accounts receivable | 43,244 | 74,675 | 41,865 | (6,364 | ) | ||||||||||
| Inventories | (22,757 | ) | (10,290 | ) | (29,964 | ) | 12,554 | ||||||||
| Income tax receivables | (2,832 | ) | (55 | ) | (4,145 | ) | 3,165 | ||||||||
| Prepaid expenses and other | (41,750 | ) | 1,152 | (45,203 | ) | (2,140 | ) | ||||||||
| Accounts payable | 36,637 | (16,099 | ) | 33,705 | 14,443 | ||||||||||
| Accrued expenses and other | (19,756 | ) | 11,387 | (34,928 | ) | 18,484 | |||||||||
| Income tax payable | (1,969 | ) | (10,568 | ) | (4,653 | ) | (730 | ) | |||||||
| Lease liabilities | (2,595 | ) | (9,464 | ) | (5,730 | ) | (8,050 | ) | |||||||
| Deferred revenue | 20,050 | (14,053 | ) | 47,120 | (78,165 | ) | |||||||||
| Net cash provided by operating activities | 44,935 | 71,618 | 96,394 | 137,974 | |||||||||||
| Investing activities | |||||||||||||||
| Purchase of property, plant and equipment | (1,077 | ) | (2,191 | ) | (5,604 | ) | (11,615 | ) | |||||||
| Retirement/disposal of property, plant and equipment | (1 | ) | — | 38 | — | ||||||||||
| Sale of equity investment | 11,975 | — | 11,975 | — | |||||||||||
| Net cash provided by (used in) investing activities | 10,897 | (2,191 | ) | 6,409 | (11,615 | ) | |||||||||
| Financing activities | |||||||||||||||
| Series A equity issuance costs | — | (1 | ) | — | (1,509 | ) | |||||||||
| Tax withholding related to vesting of equity-based compensation | (1,154 | ) | — | (1,734 | ) | — | |||||||||
| Proceeds from issuance of other debt | 6,340 | 36,715 | 19,024 | 60,516 | |||||||||||
| Principal payments on other debt | (12,208 | ) | (30,767 | ) | (24,879 | ) | (69,024 | ) | |||||||
| Principal payments on term loan facility | (1,075 | ) | (51,075 | ) | (3,225 | ) | (73,225 | ) | |||||||
| Contingent consideration payments | — | — | (1,427 | ) | (1,200 | ) | |||||||||
| Net cash used in financing activities | (8,097 | ) | (45,128 | ) | (12,241 | ) | (84,442 | ) | |||||||
| Effect of exchange rate changes on cash and cash equivalent balances | 2,317 | (6,255 | ) | (7,270 | ) | (1,808 | ) | ||||||||
| Net change in cash and cash equivalents | 50,052 | 18,044 | 83,292 | 40,109 | |||||||||||
| Cash and cash equivalents, beginning of | 282,320 | 155,966 | 249,080 | 133,901 | |||||||||||
| Cash and cash equivalents, end of period | $ | 332,372 | $ | 174,010 | $ | 332,372 | $ | 174,010 | |||||||
| Supplemental cash flow information | |||||||||||||||
| Cash paid for interest | $ | 11,847 | $ | 20,256 | $ | 29,666 | $ | 36,136 | |||||||
| Cash paid for income taxes (net of refunds) | $ | 8,219 | $ | 18,313 | $ | 25,220 | $ | 36,797 | |||||||
| Non-cash investing and financing | |||||||||||||||
| Dividends accrued on Series A | $ | 7,132 | $ | 6,696 | $ | 20,914 | $ | 19,567 | |||||||
The following table reconciles Gross profit to Adjusted gross profit:
| ARRAY Technologies, Inc. Adjusted Gross Profit, Adjusted EBITDA, Adjusted Net Income, and Free Cash Flow Reconciliation (unaudited) (in thousands, except per share amounts) | |||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||
| Revenue | 231,406 | 350,438 | 640,575 | 1,234,936 | |||||||
| Cost of revenue | 153,091 | 263,059 | 421,217 | 903,614 | |||||||
| Gross profit | 78,315 | 87,379 | 219,358 | 331,322 | |||||||
| Gross margin | 33.8 | % | 24.9 | % | 34.2 | % | 26.8 | % | |||
| Amortization of developed technology | 3,639 | 3,640 | 10,918 | 10,918 | |||||||
| Adjusted gross profit | 81,954 | 91,019 | 230,276 | 342,240 | |||||||
| Adjusted gross margin | 35.4 | % | 26.0 | % | 35.9 | % | 27.7 | % | |||
The following table reconciles Net income to Adjusted EBITDA:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Net (loss) income | $ | (141,354 | ) | $ | 23,098 | $ | (113,491 | ) | $ | 117,898 | |||||
| Preferred dividends and accretion | 14,080 | 13,091 | 41,332 | 38,359 | |||||||||||
| Net (loss) income to common shareholders | $ | (155,434 | ) | $ | 10,007 | $ | (154,823 | ) | $ | 79,539 | |||||
| Other expense, net | (3,541 | ) | (2,979 | ) | (11,023 | ) | (5,997 | ) | |||||||
| Foreign currency loss (gain), net | 106 | (207 | ) | 1,073 | (273 | ) | |||||||||
| Preferred dividends and accretion | 14,080 | 13,091 | 41,332 | 38,359 | |||||||||||
| Interest expense | 8,264 | 13,064 | 25,818 | 35,372 | |||||||||||
| Income tax expense | 3,850 | 7,229 | 12,964 | 36,904 | |||||||||||
| Depreciation expense | 1,232 | 709 | 3,270 | 1,897 | |||||||||||
| Amortization of intangibles | 8,274 | 9,196 | 25,669 | 28,420 | |||||||||||
| Amortization of developed technology | 3,639 | 3,640 | 10,918 | 10,918 | |||||||||||
| Equity-based compensation | 2,023 | 3,350 | 6,851 | 11,930 | |||||||||||
| Change in fair value of contingent consideration | (39 | ) | 190 | (271 | ) | 2,232 | |||||||||
| Goodwill impairment | 162,000 | — | 162,000 | — | |||||||||||
| Certain legal expenses (a) | 2,270 | 103 | 4,533 | 654 | |||||||||||
| Other costs (b) | — | — | 42 | — | |||||||||||
| Adjusted EBITDA | $ | 46,724 | $ | 57,393 | $ | 128,353 | $ | 239,955 | |||||||
(a) Represents certain legal fees and other related costs associated with (i) Actions filed against the company and certain officers and directors alleging violations of the Securities Exchange Acts of 1934 and 1933, which litigation was dismissed with prejudice by the Court on May 19, 2023 and subsequently appealed. The appeal has been fully briefed, argued, and the Company is awaiting a decision, and (ii) other litigation and legal matters. We consider these costs not representative of legal costs that we will incur from time to time in the ordinary course of our business.
(b) For the nine months ended September 30, 2024, other costs represent costs related to Capped-Call accounting treatment evaluation.
The following table reconciles Net income to Adjusted net income:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Net (loss) income | $ | (141,354 | ) | $ | 23,098 | $ | (113,491 | ) | $ | 117,898 | |||||
| Preferred dividends and accretion | 14,080 | 13,091 | 41,332 | 38,359 | |||||||||||
| Net (loss) income to common shareholders | $ | (155,434 | ) | $ | 10,007 | $ | (154,823 | ) | $ | 79,539 | |||||
| Amortization of intangibles | 8,274 | 9,196 | 25,669 | 28,420 | |||||||||||
| Amortization of developed technology | 3,639 | 3,640 | 10,918 | 10,918 | |||||||||||
| Amortization of debt discount and issuance costs | 1,551 | 4,125 | 4,652 | 9,123 | |||||||||||
| Preferred accretion | 6,947 | 6,394 | 20,417 | 18,792 | |||||||||||
| Equity based compensation | 2,023 | 3,350 | 6,851 | 11,930 | |||||||||||
| Change in fair value of contingent consideration | (39 | ) | 190 | (271 | ) | 2,232 | |||||||||
| Goodwill impairment | 162,000 | — | 162,000 | — | |||||||||||
| Certain legal expenses (a) | 2,270 | 103 | 4,533 | 654 | |||||||||||
| Other costs(b) | — | — | 42 | — | |||||||||||
| Income tax expense of adjustments(c) | (4,771 | ) | (5,354 | ) | (13,908 | ) | (16,106 | ) | |||||||
| Adjusted net income | $ | 26,460 | $ | 31,651 | $ | 66,080 | $ | 145,502 | |||||||
| (Loss) income per common share | |||||||||||||||
| Basic | $ | (1.02 | ) | $ | 0.07 | $ | (1.02 | ) | $ | 0.52 | |||||
| Diluted | $ | (1.02 | ) | $ | 0.07 | $ | (1.02 | ) | $ | 0.52 | |||||
| Weighted average number of common shares outstanding | |||||||||||||||
| Basic | 151,923 | 151,068 | 151,691 | 150,865 | |||||||||||
| Diluted | 151,923 | 152,323 | 151,691 | 152,083 | |||||||||||
| Adjusted net income per common share | |||||||||||||||
| Basic | $ | 0.17 | $ | 0.21 | $ | 0.44 | $ | 0.96 | |||||||
| Diluted | $ | 0.17 | $ | 0.21 | $ | 0.43 | $ | 0.96 | |||||||
| Weighted average number of common shares outstanding | |||||||||||||||
| Basic | 151,923 | 151,068 | 151,691 | 150,865 | |||||||||||
| Diluted | 152,135 | 152,323 | 152,186 | 152,083 | |||||||||||
(a) Represents certain legal fees and other related costs associated with (i) Actions filed against the company and certain officers and directors alleging violations of the Securities Exchange Acts of 1934 and 1933, which litigation was dismissed with prejudice by the Court on May 19, 2023 and subsequently appealed. The appeal has been fully briefed, argued, and the Company is awaiting a decision, and (ii) other litigation and legal matters. We consider these costs not representative of legal costs that we will incur from time to time in the ordinary course of our business.
(b) For the nine months ended September 30, 2024, other costs represent costs related to Capped-Call accounting treatment evaluation.
(c) Represents the estimated tax impact of all Adjusted Net Income add-backs, excluding those which represent permanent differences between book versus tax.
The following table reconciles new cash provided by operating activities to Free cash flow:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||
| Net cash provided by operating activities | 44,935 | 71,618 | 96,394 | 137,974 | |||||||
| Purchase of property, plant and equipment | (1,077 | ) | (2,191 | ) | (5,604 | ) | (11,615 | ) | |||
| Free cash flow | 43,858 | 69,427 | 90,790 | 126,359 | |||||||
FAQ
What was ARRAY Technologies (ARRY) revenue in Q3 2024?
What is ARRAY Technologies (ARRY) full-year 2024 revenue guidance?
What was ARRAY Technologies (ARRY) net loss in Q3 2024?
What is ARRAY Technologies (ARRY) current orderbook value?
